24-27 November 2026Crocus Expo, Pavilion 2, Moscow
RU
The atmosphere of Pharmtech & Ingredients 2025 was filled with energy, active communication and fruitful discussions. Participants successfully presented their solutions, and visitors were able to find answers to the most pressing requests, establish valuable business contacts and conclude promising agreements. The exhibition has become an effective platform for strengthening partnerships, finding new suppliers and demonstrating the achievements of the industry.
In 4 days, the exhibition gathered 10,748 unique visitors, and this is a new record for attendance, which is 4% higher than last year. The geography of visitors is also impressive: specialists came from 71 regions of Russia and 29 countries of the world, including representatives of all EAEU countries (Belarus, Armenia, Kyrgyzstan, Kazakhstan), which indicates the highest interest of the professional community in the presented innovations and solutions. The share of new visitors was 51%: 5,443 specialists did not visit Pharmtech & Ingredients a year earlier. More than 2,600 visitors (42%) represented companies with procurement budgets of 20 million and more than 50 million rubles.
Among the visitors of the exhibition 2025 were representatives of such leading companies as Akrikhin, Bayer, Belmedpreparaty, Binnopharm, Biocad, Veropharm, Vertex, Geropharm, Novamedica, Ozone Pharmaceuticals, Petrovax Pharm, R-Pharm, Samson-Med, Sber Eapteka, Evalar and many others.
 |  |
The exhibition was attended by 534 companies from 9 countries of the world (Russia, Belarus, India, China, Turkey, South Korea and other countries), which presented the latest developments in the field of equipment, technologies, raw materials and solutions for all stages of pharmaceutical production. More than 190 companies took part in the exhibition for the first time! The wide geography of participants emphasized the global importance of Pharmtech & Ingredients as a center of attraction for world industry leaders.
Among the participants from Russia: Biomirix, BWT, Gluvex, InterPharmTechnology, Lamsystems, ML Group, Neopolis, Pharm Door, Proftradelab, Sinopharmtech, Wellgo, Avivir, Aix Lab, IBC Nanotex, Alianbio, Aldosa, Alfa-Techno, Artlife, Bavar+, Belhand, Bioline, Velpharm-Group, Vladisart, Junos, Euroclima, East-Pak, Itorch, Katrosa Reaktiv, Lumex, Mirapharm, Olpharm, Polo Russia, PSK Pharma, Revada-Neva, Rolstech, Royal Service Rus, Sibur, Solid Pharma, Pharmvilar, Chembroker, Himmed, Stolzle Glas, Ekroshim, Erecton and many others.
List of participants >>
Among the participants from India: ACG, Adam Fabriwerk, Alex Pharmachem, JPN Pharma, Kesar Control Systems, Bharat Rubber Works, Caprihans India Limited (Bilcare Group), Dishman, Maithili Life Sciences, Vikram Thermo, Parle Global Technologies, Rakshit Pharmaceutical, Relco Pharma, Simson Pharma and many others.
Among the participants from China: Biogrowing, Wecare, Alphadock Technology, Tofflon, ExCell, Truking, Keno Pharma, Line-Link Purification, Farmasino, Wiggens, Asnail Biotechnology, Pharmapack technologies, Sinoped International, Canaan, and many more.
The development and high status of the exhibition is also confirmed by the presence of sponsors. This year, PSK Pharma, a Russian manufacturer of hollow hard gelatin capsules under the PharmCaps brand, became a Platinum Partner of the exhibition. These capsules are manufactured under strictly controlled conditions in accordance with GMP requirements and on state-of-the-art automated production lines, which ensures the quality of the capsules is world-class. The general partner of the exhibition is Biogrowing, which specializes in the research, development, production and sale of complex probiotic products. The official partner of the exhibition, Wecare, specializes in the research, development and production of probiotic and starter cultures, as well as the use of strains. The partners of the entrance group of the exhibition were Neopolis and Alphadock. Neopolis is the second largest manufacturer of flexible packaging in Russia, among the key areas of the company is the production of packaging for pharmaceutical and cosmetic products. Alphadock has been specializing in the production of solid dosage forms for the pharmaceutical industry for more than a decade, with a focus on the development of valve solutions with a high degree of tightness OEB5. Wellgo, the digital partner of the exhibition , offers a full range of solutions for the transportation of medicines at all stages of the life cycle of medicines and has comprehensive solutions for the transportation of temperature-sensitive goods. This year, for the first time, a drinking water station operated at the exhibition, in partnership with BWT. In the 8th hall there were dispensers with drinking water with different tastes, all visitors and participants of the exhibition could treat themselves to drinking water after long negotiations and active work at the exhibition. BWT is a leader in the production and technology of water treatment. One of the leading areas of the company's activity is the preparation of water for pharma. production.
 |  |
"We are always happy to have our regular partners, and there are also many new customers. We often conclude new contracts at the exhibition, and we have already implemented more than one project after meeting at the exhibition. The exhibition is a very good start for us for next year." Ekaterina Raspartova, Deputy General Director, ROLSTECH
"We believe that Pharmtech & Ingredients is the best place in the country for business contacts. Every year, colleagues from all leading enterprises come here and not only from our country, but also from Belarus, Kazakhstan and other countries - everyone who works in our large friendly pharmaceutical family." Alexander Pshenichny, Chief Executive Officer, POLISINTEZ
"For us, Pharmtech & Ingredients is a platform where we can meet with all pharmaceutical enterprises in a short time. I would call this the main advantage of the exhibition. Indeed, enterprises are coming from all over the country, and our clients, both real and potential, are walking along the corridors. We will certainly participate in the next exhibition in an even wider format - you will see how great it is, we have grown in 1 year." Dmitry Zhukov, Commercial Director, NEOPOLIS
The rich business program of the exhibition also demonstrated impressive results. 20 events of the business program were attended by 1313 specialists, which is 22% higher than last year. This confirms the relevance and acuteness of the topics discussed, the high level of experts and the desire of market participants to gain new knowledge, exchange experience and find solutions for their production problems. Within the framework of the program, key issues of import substitution, localization, digitalization, GMP standards, biotechnology, quality control and testing were considered.
Key topics of the 2025 business programme:
// Traceability of the origin of APIs. From Experiment to Everyday Practice in the EAEU Space
// "The Second Odd Man Out": Criteria, Rules, Preferences
// Biologically active additives (BAA): analytics, regulation and consumption culture
// The New Era of Dietary Supplements 2.0 – From Clinical Guidelines to Site Inspections
// FOR THE FIRST TIME! Skincare Cosmetics Market: Analytics, Regulation, Trends and Growth Drivers
// From import substitution to technological leadership. New challenges for the Russian veterinary pharma
// FOR THE FIRST TIME! ColdChain: Pharma Logistics
// Presentation of innovative projects in the field of quality of the finalists of the GxP-PROFI 2025 competition
// Raw Materials and Ingredients for Pharmaceutical Production
// Packaging materials and equipment for pharmaceutical production
// Technologies, equipment, related processes and products for pharmaceutical production
// Pharmaceutical business with China: how to create a joint venture, protect intellectual property and manage payments
 |  |
Among the speakers:
// Olga Kravtsova, Deputy Director of the Department for the Development of the Pharmaceutical and Medical Industry, Ministry of Industry and Trade of the Russian Federation
// Vladislav Shestakov, Director of the SID and GP of the Ministry of Industry and Trade of the Russian Federation
// Alexey Donskikh, Director of Pharma and Dietary Supplements, Skolkovo Foundation
// Alexander Zhestkov, Executive Director, SRO SP BAD
// Timur Chibilyaev, Executive Director, National Veterinary Association
// Semyon Zhavoronkov, Executive Director, Association of Veterinary Pharmaceutical Manufacturers
// Alexey Mikheev, Director of Market Access, Promomed Group
// Philip Romanov, General Director, Association of Participants in the Circulation of Medicines and Medical Products "LEKMEDOBRASCHENIE"
// Lyudmila Shcherbakova, President, Bright Way Group
// Evgenia Shapiro, General Director, PSK Pharma
// Dmitry Zaitsev, Chief Executive Officer, Pharmstandard
// Dmitry Nakhamchen, Director for Government Relations and Market Access, Geropharm
// Yury Zhulyov, Co-Chairman, All-Russian Union of Patients
// Victoria Presnyakova, Director, SRO Association of Independent Pharmacies
// Ilya Magerya, Founder of the Brand, Zhiznevek LLC
// Yuriy Barsukov, President, Association "Vetbioprom"
// Vasilina Gritsyuk, Deputy Director, VGNKI
// Irina Spichak, Executive Director, EARP
FOR THE FIRST TIME! This year, "Interview Point" was launched - a series of interviews with participants and industry experts - representatives of industry ministries and departments, associations, manufacturers of medicines and participants of the exhibition. We learned the opinions and forecasts of market participants, analyzed key problems and challenges, discussed opportunities and prospects for the development of the industry. Together with the GxPnews portal and its editor-in-chief Veronika Kulakova, a series of interviews was conducted, where they talked about the topic "Pharma-2030: a look from the inside".
Among the speakers:
// Vladislav Shestakov, Director of the FSI "SID and GP of the Ministry of Industry and Trade of the Russian Federation"
// Alexander Bykov, Director for Healthcare Economics, R-Pharm
// Evgeniya Shapiro, General Director, PSK Pharma
// Dmytro Nakhamchen, Director for Government Relations and Market Access, Geropharm LLC
// Irina Vendilo, General Director, Roskhimreaktiv Association
// Vladimir Gegechkori, Director of Production and Certification of Production and Certification, NCSR
// Irina Spichak, Doctor of Pharmacy, Professor, Executive Director, Eurasian Academy of Good Practices
// Grigory Cherchenko, General Director, Sofrinsky Packaging Manufactories
// Vladimir Smirnov, General Director, Mediana-Filter
 |  |
The partner of the business program of the exhibition was Statandox LLC.
The partners of the Pharmtechprom Forum sessions were Tofflon, InterPharmTechnology, and ExCell.
In 2025, Pharmtech & Ingredients was held with the official support of the Ministry of Industry and Trade of the Russian Federation, the Association of Russian Pharmaceutical Manufacturers, the Union of Professional Pharmaceutical Organizations, the Association of Pharmaceutical Manufacturers of the Eurasian Economic Union, and the Association of Independent Pharmacies.
// GxP News – General Media Partner
The exhibition was held with the information support of: the newspaper "Pharmaceutical Bulletin", the Information and Analytical Journal "CHEMICAL EXPERT", the Journal "Pharmaceutical Technologies and Packaging", the National Pharmaceutical Journal, the information portal "Development and Registration of Medicines", "Kazakhstan Pharmaceutical Bulletin", "Pharmaceutical Review of Kazakhstan", the journal "Laboratory and Production", the federal magazine "Business Russia", the information portal " INPHARM", "Pharma RF", "Healthcare of Russia", the industry portal "PHARMPROM", the portal "Remedium", the publishing house "August Borg", the portal "Ruhim.ru", the portal/magazine "SpaceHealth Space", the portal "Cosmetology-info.ru", "Moscow Pharmacies", "AptekaMos", etc.
